Trials / Completed
CompletedNCT01890291
Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.
Long Term Study of 'Immuncell-LC Groups' and 'Non-treatment Groups' in Patient Undergo Curative Resection (PEIT, Radiofrequency Ablation [RFA] or Operation) for Hepatocellular Carcinoma in Korea
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 162 (actual)
- Sponsor
- GC Cell Corporation · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To observation that long term follow-up study of 'Immuncell-LC groups' and 'Non-treatment groups' in patient undergo curative resection (PEIT, RFA or Operation) for hepatocellular carcinoma in Korea
Conditions
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2016-01-01
- Completion
- 2016-02-01
- First posted
- 2013-07-01
- Last updated
- 2023-06-26
Locations
5 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01890291. Inclusion in this directory is not an endorsement.